Table 1. Licenseda viral and bacterial vaccines for use in humans.
| Live attenuated | Killed inactivated | Subunit | |
|---|---|---|---|
| Viral | Vaccinia | Polio (IPV) | Hepatitis B (HepB-surface antigen) |
| Polio (OPV) | Rabies | Human papilloma virus (HPV) | |
| Yellow fever | Influenza | ||
| Measles | Hepatitis A | ||
| Mumps | |||
| Rubella | |||
| Influenza | |||
| Rotavirus | |||
| Bacterial | BCG (tuberculosis) | Bordetella pertussis (whole cell) | Tetanus (toxoid) |
| Salmonella typhi (oral) | Cholera | Diphtheria (toxoid) | |
| Bacillus anthracis | Neisseria meningitidis (polysaccharide) | ||
| Bordetella pertussis (acellular) | |||
| Streptococcus pneumoniae, 23 valent (polysaccharide) | |||
| Haemophilus influenzae, type b (Hib) (polysaccharide) | |||
| Neisseria meningitidis (polysaccharide conjugate) | |||
| Streptococcus pneumoniae, heptavalent (conjugate polysaccharides) | |||
| Salmonella typhi Vi (capsular polysaccharide) |
a
Licensed by national regulatory agencies such as ANVISA in Brazil or FDA in the USA.
OPV = oral polio vaccine; IPV = inactivated polio vaccine; BCG = bacillus Calmette-Guérin.